New Mechanisms of Obesity
Pathogenic Mechanisms of Obesity and Its Cardiometabolic Complications
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 15 Years to 22 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
Given the pervasiveness of Pediatric Obesity, it is imperative to understand its pathophysiology and develop alternative strategies to reverse this condition. Herein, investigators propose to elucidate the interaction between colonic fermentation and insulin resistance in modulating metabolism in youth with obesity.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: * Age 15 to 22 years * In puberty (girls and boys: Tanner stage III-V); * BMI \>85th Exclusion Criteria: * Pregnancy; * endocrinopathies (e.g., Cushing syndrome); * substance abuse; * medications affecting insulin resistance such as metformin, GLP-1 analogues; - * high fibers intake (\> 30g/day) as assessed by a 3-day food record.
Study sites (1)
CT
- Yale University · New Haven, CT 06520More trials in New Haven